← Back to headlines
Lawmakers Urge FDA Scrutiny of Chinese Clinical Trials Amid Deaths
A report indicates that lawmakers are calling on the FDA to scrutinize Chinese clinical trials following reports of deaths, raising concerns about research integrity and patient safety.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
